Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma

Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Investig Med High Impact Case Rep
Главные авторы: Kichloo, Asim, Albosta, Michael S., McMahon, Shane, Movsesian, Kimberly, Wani, Farah, Jamal, Shakeel M., Aljadah, Michael, Singh, Jagmeet
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2020
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448133/
https://ncbi.nlm.nih.gov/pubmed/32830561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709620951339
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы